Transcriptomics

Dataset Information

0

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours


ABSTRACT: Inflammatory hepatocellular adenomas (IHCA) are benign liver tumours defined by the presence of inflammatory infiltrates and by the elevated expression of inflammatory proteins in tumour hepatocytes1,2. Here we show a striking activation of the IL6 signalling pathway in this tumour type, and sequencing candidate genes pinpointed this response to somatic gain-of-function mutations in the IL6ST gene that encodes the signalling co-receptor gp130. Indeed, ~70% of IHCA harbour small in-frame deletions that target the binding site of gp130 for IL6, and expression of the most frequent gp130 mutant, Delta-STVY190, in hepatocellular cells activates STAT3 in absence of ligand. Further, analysis of hepatocellular carcinomas revealed rare gp130 alterations always accompanied by ß-catenin-activating mutations, suggesting a cooperative effect of these signalling pathways in the malignant conversion of hepatocytes. The recurrent gain-of-function gp130 mutations in these human hepatocellular adenomas explains their inflammatory phenotype, and suggest that similar alterations may occur in other inflammatory epithelial tumours with STAT3 activation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE11819 | GEO | 2008/12/24

SECONDARY ACCESSION(S): PRJNA105913

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2008-12-24 | E-GEOD-11819 | biostudies-arrayexpress
2013-01-29 | E-GEOD-35808 | biostudies-arrayexpress
2013-01-29 | GSE35808 | GEO
2017-07-05 | E-MTAB-4570 | biostudies-arrayexpress
| PRJNA105913 | ENA
2015-10-01 | GSE48287 | GEO
2015-10-01 | GSE48285 | GEO
2023-10-01 | GSE198849 | GEO
2019-10-01 | GSE88839 | GEO
2023-05-09 | PXD036006 | Pride